[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Stakeholder](https://github.com/mm80843/T3.5/tree/pages/docs/Stakeholder/index.md) >> Individual ID:PBN__Stakeholder_2899 

# __Laboratory staff__

## Risk affecting this stakeholder

* [Contaminated samples during transport and storage](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3650.md)
* [Discrepancies in reported biocidal mechanisms of cu 2 o compounds for viral inactivation](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5210.md)
* [Exposure to sars-cov-2 virus during testing of the cu 2 o/pu film](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5211.md)
* [Exposure to wastewater samples during analysis](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5427.md)
* [Handling and manipulation of chemical reagents and solvents](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5502.md)
* [Handling and manipulation of viral rna samples](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5503.md)
* [Handling of dried virus and potential exposure to infectious material](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5504.md)
* [Handling sewage samples without proper pasteurization increases the risk of exposure to live viruses.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5505.md)
* [Inactivation of sars-cov-2 virus on the coated surface](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5506.md)
* [Incomplete quantification of viral titers due to lack of investigation on recovery rates for each step in the process.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5507.md)
* [Isolation and use of hcov-229e in pcr](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_8542.md)
* [Lack of enhanced infection control measures in various activities with suspected or confirmed cases, samples, material, and waste](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_9827.md)
* [Operational limitations during an outbreak leading to inconsistent methodology and small sample size](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10751.md)
* [Possible cross contamination during the purification or rna isolation step](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10762.md)
* [Potential cross-contamination between houses](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10763.md)
* [Potential false-positive results due to environmental contaminants affecting pcr](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10764.md)
* [Potential for incomplete inactivation of the virus due to variability in wettability of the cu 2 o/pu film](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11790.md)
* [Potential spread of influenza a h1n1 and human adenovirus](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11791.md)
* [Potential spread of sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11792.md)
* [Replication studies with sars-cov-2 positive wastewater](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11811.md)
* [Risk of contamination through bodily fluids and transmission through oral or conjunctival routes](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11812.md)
* [Sanger sequencing analysis](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11813.md)
* [Storage of coated samples under water for 13 days](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11814.md)
* [Storage of dust samples at 280Â°c](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11815.md)
* [Testing and quantifying viral titers in wastewater samples involves the risk of accidental exposure to sars-cov-2 virus.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11816.md)
* [Testing viral enrichment process in sewage samples can pose a risk of exposure to viral contaminants.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11817.md)
* [Transmission of contagious diseases through research activities](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11818.md)
* [Uncertain virucidal activity against specific viruses, such as sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11819.md)
* [Unspecific signal in rt-qpcr due to environmental contaminants](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11865.md)
* [Use of mass spectrometric equipment and analysis](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12167.md)
* [Use of specific chemicals such as formaldehyde and acetaldehyde in the testing process can pose health risks to individuals.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17124.md)
* [Use of specific pcr conditions for detecting viruses](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18562.md)
* [Verification of specificity and sensitivity of rna sequencing](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_20261.md)

## Risks that can be mitigated by this stakeholder

* [Discrepancies in reported biocidal mechanisms of cu 2 o compounds for viral inactivation](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5502.md)
* [Handling and manipulation of viral rna samples](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5503.md)
* [Incomplete quantification of viral titers due to lack of investigation on recovery rates for each step in the process.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5504.md)
* [Potential for incomplete inactivation of the virus due to variability in wettability of the cu 2 o/pu film](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10751.md)
* [Uncertain virucidal activity against specific viruses, such as sars-cov-2](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11817.md)
* [Use of specific pcr conditions for detecting viruses](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11818.md)
* [Verification of specificity and sensitivity of rna sequencing](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_11819.md)

## This Stakeholder belongs to this Stakeholder Group

* [Health organisations](https://github.com/mm80843/T3.5/blob/pages/StakeholderGroup/PBN__StakeholderGroup_7.md)

## This Stakeholder belongs to this Stakeholder Subgroup

* [Medical and healthcare personnel](https://github.com/mm80843/T3.5/blob/pages/StakeholderSubgroup/PBN__StakeholderSubgroup_15.md)

